{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:26:52Z","timestamp":1761823612848,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T00:00:00Z","timestamp":1385337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jsbmb.2013.11.013","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T03:46:54Z","timestamp":1385437614000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"PA","title":["Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo"],"prefix":"10.1016","volume":"144","author":[{"given":"Hitoshi","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jsbmb.2013.11.013_bib0005","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.jsbmb.2013.11.013_bib0010","first-page":"719","article-title":"Newly identified actions of the vitamin D endocrine system","volume":"13","author":"Walters","year":"1992","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.jsbmb.2013.11.013_bib0015","first-page":"200","article-title":"Structure\u2013function relationships in the vitamin D endocrine system","volume":"16","author":"Bouillon","year":"1995","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.jsbmb.2013.11.013_bib0020","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1073\/pnas.95.4.1387","article-title":"Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter","volume":"95","author":"Brenza","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.jsbmb.2013.11.013_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/bbrc.1998.9098","article-title":"The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3","volume":"249","author":"Murayama","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.jsbmb.2013.11.013_bib0030","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo.140.5.6691","article-title":"Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals","volume":"140","author":"Murayama","year":"1999","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jsbmb.2013.11.013_bib0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.jsbmb.2013.11.013_bib0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1359\/jbmr.1998.13.3.325","article-title":"The nuclear vitamin D receptor: biological and molecular regulatory properties revealed","volume":"13","author":"Haussler","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.jsbmb.2013.11.013_bib0045","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/oxfordjournals.jbchem.a022662","article-title":"The function of vitamin D receptor in vitamin D action","volume":"127","author":"Kato","year":"2000","journal-title":"J. Biochem."},{"issue":"4","key":"10.1016\/j.jsbmb.2013.11.013_bib0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jcb.10423","article-title":"New insights into the mechanisms of vitamin D action","volume":"88","author":"Christakos","year":"2003","journal-title":"J. Cell Biochem."},{"issue":"4","key":"10.1016\/j.jsbmb.2013.11.013_bib0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng0897-391","article-title":"Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning","volume":"16","author":"Yoshizawa","year":"1997","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.jsbmb.2013.11.013_bib0060","first-page":"156","article-title":"The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets","volume":"20","author":"Malloy","year":"1999","journal-title":"Endocr. Rev."},{"issue":"12","key":"10.1016\/j.jsbmb.2013.11.013_bib0065","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1210\/endo.142.12.8544","article-title":"Aberrant growth plate development in VDR\/RXR gamma double null mutant mice","volume":"142","author":"Yagishita","year":"2001","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jsbmb.2013.11.013_bib0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.abb.2011.12.020","article-title":"Recent advances in our understanding of 1,25-dihydroxyvitamin D(3) regulation of intestinal calcium absorption","volume":"523","author":"Christakos","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.jsbmb.2013.11.013_bib0075","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bone.2011.07.011","article-title":"A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures\u2014a randomized, active comparator, double-blind study","volume":"49","author":"Matsumoto","year":"2011","journal-title":"Bone"},{"issue":"1-2","key":"10.1016\/j.jsbmb.2013.11.013_bib0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jsbmb.2010.03.035","article-title":"Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism","volume":"121","author":"Matsumoto","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.jsbmb.2013.11.013_bib0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00296065","article-title":"A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy)1 alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats","volume":"54","author":"Tsurukami","year":"1994","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.jsbmb.2013.11.013_bib0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jbmr.5650110306","article-title":"Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats","volume":"11","author":"Tanaka","year":"1996","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2013.11.013_bib0095","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S8756-3282(02)00682-8","article-title":"ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis","volume":"30","author":"Uchiyama","year":"2002","journal-title":"Bone"},{"issue":"3\u20135","key":"10.1016\/j.jsbmb.2013.11.013_bib0100","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jsbmb.2006.12.088","article-title":"ED-71, a new active vitamin D3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects","volume":"103","author":"Matsumoto","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2013.11.013_bib0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bone.2012.12.001","article-title":"Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats","volume":"53","author":"Takeda","year":"2013","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.jsbmb.2013.11.013_bib0110","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00223-011-9528-7","article-title":"The vitamin D analog 1alpha,25-dihydroxy-2beta-(3-hydroxypropyloxy) vitamin D(3) (eldecalcitol) is a potent regulator of calcium and phosphate metabolism","volume":"89","author":"Brown","year":"2011","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.jsbmb.2013.11.013_bib0115","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/0006-291X(89)91140-6","article-title":"Regulatory activities of 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism","volume":"163","author":"Okano","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.jsbmb.2013.11.013_bib0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0024-3205(97)01139-9","article-title":"Differential time course of induction of 1\u03b1,25-dihydroxyvitamin D3-24-hydroxylase mRNA expression in rats by 1\u03b1,25-dihydroxyvitamin D3 and its analogs","volume":"62","author":"Furuichi","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.jsbmb.2013.11.013_bib0125","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/jcb.23051","article-title":"Suppression of PTH by the vitamin D analog eldecalcitol is modulated by its high affinity for the serum vitamin D-binding protein and resistance to metabolism","volume":"112","author":"Ritter","year":"2011","journal-title":"J. Cell Biochem."},{"issue":"6","key":"10.1016\/j.jsbmb.2013.11.013_bib0130","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1248\/cpb.41.1111","article-title":"Synthetic studies of vitamin D analogues. XIV. Synthesis and calcium regulating activity of vitamin D3 analogues bearing a hydroxyalkoxy group at the 2 beta-position","volume":"41","author":"Miyamoto","year":"1993","journal-title":"Chem. Pharm. Bull. (Tokyo)"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076013002689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076013002689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:43:31Z","timestamp":1760744611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076013002689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":26,"alternative-id":["S0960076013002689"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.11.013","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}